| Basics |
|
Genprex, Inc.
|
| IPO Date: |
March 29, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$7.63M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 5.28%
|
| Avg Daily Range (30 D): |
$0.48 | 8.53%
|
| Avg Daily Range (90 D): |
$0.25 | 9.79%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.89M |
| Avg Daily Volume (30 D): |
.5M |
| Avg Daily Volume (90 D): |
14.4M |
| Trade Size |
| Avg Trade Size (Sh.): |
375 |
| Avg Trade Size (Sh.) (30 D): |
57 |
| Avg Trade Size (Sh.) (90 D): |
616 |
| Institutional Trades |
| Total Inst.Trades: |
29 |
| Avg Inst. Trade: |
$1.57M |
| Avg Inst. Trade (30 D): |
$1.18M |
| Avg Inst. Trade (90 D): |
$1.18M |
| Avg Inst. Trade Volume: |
M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.5M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
.48K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$334.18
|
$-5
|
$-.17
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -16.77M
|
$ -3.8M
|
$ -4.67M
|
|
Operating Income / Loss
|
$ -16.33M
|
$ -3.35M
|
$ -4.68M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ .11M
|
$ M
|
$ M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 21, 2025:
1:50
|
|
Feb 02, 2024:
1:40
|
|
|
|